Tecrea are pioneers in the field of molecular science. By creating a patented nanotechnology platform, we provide a unique range of cell and tissue delivery tools that are fully translatable from the lab to the clinic.

What does that mean in practice? It means that you, our partners, and the wider biomedical research community have access to novel delivery reagents that offer unparalleled opportunities to advance drug development and research, without compromising on experiment integrity.

Using nanoparticle-forming technology, our Tecrea scientists have developed Nanocin – a range of transfection, small molecule, protein and peptide delivery reagents that are able to facilitate unsurpassed levels of accuracy, speed and yield.

Relying on a dynamic system that rapidly self-assembles molecules and then “packages” them into nanoparticles, our platform significantly enhances cellular delivery into both mammalian and bacterial cells.

All of this is achieved whilst maintaining >99% cell viability; a unique feature of our nanotechnology that distinguishes Nanocin from other reagent tools.

Links and Resources

• Plasmid Transfection Protocol